|
Index of reports
> Cases resulting in life threatening events (34)
> Cases with Hepatic Enzyme Increased (5)
Below is the selection of adverse event reports related to Zetia (Ezetimibe) that includes cases resulting in life threatening events where reactions include hepatic enzyme increased.
Adverse event in 50 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Australia on 2007-06-22
Patient: 50 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Ischaemia, Hepatitis Acute, Anaemia, Cardiac Output Decreased, Hepatic Enzyme Increased, Death, Renal Failure, Hepatomegaly, Chronic Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zetia
Administration route: Oral
Indication: Hypertension
Start date: 2004-08-01
End date: 2004-09-27
Zetia
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2004-08-01
End date: 2004-09-27
Lipitor
Administration route: Oral
Start date: 2003-01-01
End date: 2004-09-27
Coversyl (Perindopril Erbumine)
Administration route: Oral
Start date: 2004-08-19
Lasix
Indication: Ischaemia
Start date: 2003-01-01
Lasix
Indication: Left Ventricular Failure
Start date: 2003-01-01
Other drugs received by patient: Clopidogrel Bisulfate; Carvedilol; [composition Unspecified]
Adverse event in 50 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Australia on 2007-06-13
Patient: 50 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Ischaemia, Hepatitis Acute, Anaemia, Cardiac Output Decreased, Cardiac Disorder, Hepatic Enzyme Increased, Death, Renal Failure, Hepatomegaly, Chronic Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zetia
Administration route: Oral
Indication: Hypertension
Start date: 2004-08-01
End date: 2004-09-27
Zetia
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2004-08-01
End date: 2004-09-27
Lipitor
Administration route: Oral
Start date: 2003-01-01
End date: 2004-09-27
Coversyl (Perindopril Erbumine)
Administration route: Oral
Start date: 2004-08-19
Lasix
Indication: Ischaemia
Start date: 2003-01-01
Lasix
Indication: Left Ventricular Failure
Start date: 2003-01-01
Other drugs received by patient: Clopidogrel Bisulfate; Carvedilol; [composition Unspecified]
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-06-04
Patient: male
Adverse reactions / side effects: Haemoglobin Decreased, Renal Failure, Hepatic Failure, Blood Creatine Increased, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Lipitor; Lopid
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-05-18
Patient: female
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-04-18
Patient: female
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Zetia (Ezetimibe)
|
